FI103668B1 - Menetelmä farmakologisesti aktiivisten pyrrolo[3,2-e]indol-4(5H)-onidimeerien valmistamiseksi - Google Patents

Menetelmä farmakologisesti aktiivisten pyrrolo[3,2-e]indol-4(5H)-onidimeerien valmistamiseksi

Info

Publication number
FI103668B1
FI103668B1 FI911193A FI911193A FI103668B1 FI 103668 B1 FI103668 B1 FI 103668B1 FI 911193 A FI911193 A FI 911193A FI 911193 A FI911193 A FI 911193A FI 103668 B1 FI103668 B1 FI 103668B1
Authority
FI
Finland
Prior art keywords
pct
unidimers
indole
preparation
pharmacologically active
Prior art date
Application number
FI911193A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI911193A0 (fi
FI103668B (fi
Inventor
Robert C Kelly
Paul A Aristoff
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FI911193A0 publication Critical patent/FI911193A0/fi
Application granted granted Critical
Publication of FI103668B1 publication Critical patent/FI103668B1/fi
Publication of FI103668B publication Critical patent/FI103668B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Error Detection And Correction (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Amplifiers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Artificial Filaments (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • Solid State Image Pick-Up Elements (AREA)
  • Television Systems (AREA)
  • Television Receiver Circuits (AREA)
  • Stereophonic System (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
FI911193A 1988-09-12 1991-03-11 Menetelmä farmakologisesti aktiivisten pyrrolo£3,2-e|indol-4(5H)-onidi meerien valmistamiseksi FI103668B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24335088A 1988-09-12 1988-09-12
US24335088 1988-09-12
US8903329 1989-08-07
PCT/US1989/003329 WO1990002746A1 (en) 1988-09-12 1989-08-07 Novel cc-1065 analogs having two cpi subunits

Publications (3)

Publication Number Publication Date
FI911193A0 FI911193A0 (fi) 1991-03-11
FI103668B1 true FI103668B1 (fi) 1999-08-13
FI103668B FI103668B (fi) 1999-08-13

Family

ID=22918400

Family Applications (1)

Application Number Title Priority Date Filing Date
FI911193A FI103668B (fi) 1988-09-12 1991-03-11 Menetelmä farmakologisesti aktiivisten pyrrolo£3,2-e|indol-4(5H)-onidi meerien valmistamiseksi

Country Status (14)

Country Link
US (1) US5541339A (enExample)
JP (1) JP3380237B2 (enExample)
KR (1) KR0137959B1 (enExample)
AT (1) ATE198335T1 (enExample)
AU (1) AU632288B2 (enExample)
CA (1) CA1340215C (enExample)
DE (1) DE68929275T2 (enExample)
DK (1) DK175458B1 (enExample)
FI (1) FI103668B (enExample)
GR (1) GR3035589T3 (enExample)
LV (1) LV12806B (enExample)
NO (1) NO303498B1 (enExample)
TW (1) TW217383B (enExample)
WO (1) WO1990002746A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69231123T2 (de) * 1992-03-25 2001-02-15 Immunogen Inc Konjugaten von Zell-bindender Mittel und Derivaten von CC-1065
US5502068A (en) * 1995-01-31 1996-03-26 Synphar Laboratories, Inc. Cyclopropylpyrroloindole-oligopeptide anticancer agents
JP4414142B2 (ja) 2001-05-11 2010-02-10 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ 特異的結合タンパク質およびその使用
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
BR0214019A (pt) 2001-11-09 2004-10-13 Boehringer Ingelheim Phamaceut Benzimidazóis úteis como inibidores de proteìna quinase
AU2003257094A1 (en) * 2002-08-08 2004-02-25 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted benzimidazole compounds
WO2004035571A1 (en) * 2002-10-15 2004-04-29 Rigel Pharmaceuticals, Inc. Substituted indoles and their use as hcv inhibitors
CA2531485C (en) * 2003-07-07 2013-03-26 Merck Patent Gmbh Malonamide derivatives
US20050209284A1 (en) * 2004-02-12 2005-09-22 Boehringer Ingelheim Pharmaceuticals, Inc. Tec kinase inhibitors
US7446195B2 (en) * 2005-08-17 2008-11-04 Schering Corporation High affinity thiophene-based and furan-based kinase ligands
CN104013956B (zh) 2007-01-25 2018-12-18 达娜-法勃肿瘤研究所公司 抗egfr抗体在治疗egfr突变体介导的疾病中的用途
CA2680854C (en) 2007-03-15 2017-02-14 Ludwig Institute For Cancer Research Treatment method using egfr antibodies and src inhibitors and related formulations
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
CN108424454B (zh) 2007-08-14 2022-05-31 路德维格癌症研究所有限公司 靶向egf受体的单克隆抗体175及其衍生物和用途
NO2344478T3 (enExample) 2008-11-03 2018-02-24
MX374267B (es) 2010-04-21 2025-03-06 Syntarga Bv Conjugados novedosos de analogos cc-1065 y ligaduras bifuncionales.
EP2908809A2 (en) 2012-10-22 2015-08-26 Arnold Glazier Methods for the effective treatment of metastatic cancer
DE102013012622A1 (de) * 2013-07-30 2015-02-05 Clariant lnternational Ltd Neue sterisch gehinderte cyclische Amine
MX373458B (es) 2014-01-10 2020-05-11 Byondis Bv Metodo para purificar conjugados de anticuerpo-farmaco enlazados a cisteina.
HUE043427T2 (hu) * 2014-01-27 2019-08-28 Pfizer Bifunkciós citotoxikus szerek
AU2015282627B2 (en) 2014-06-30 2020-04-02 Glykos Finland Oy Saccharide derivative of a toxic payload and antibody conjugates thereof
DE102015000124A1 (de) * 2015-01-07 2016-07-07 Clariant International Ltd. Verfahren zur Stabilisierung von Polyamiden
WO2016151432A1 (en) * 2015-03-20 2016-09-29 Pfizer Inc. Bifunctional cytotoxic agents containing the cti pharmacophore

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169888A (en) * 1977-10-17 1979-10-02 The Upjohn Company Composition of matter and process
US4301248A (en) * 1979-12-21 1981-11-17 Bristol-Myers Company Fermentation process for making rachelmycin
US4413132A (en) * 1980-11-18 1983-11-01 The Upjohn Company Antibiotic CC-1065 indoline intermediates
CA1238907A (en) * 1984-02-21 1988-07-05 Robert C. Kelly 1,2,8,8a-tetrahydrocyclopropa¬c|pyrrolo(3,2-e)- indol-4(5h)-ones and related compounds
US4912227A (en) * 1984-02-21 1990-03-27 The Upjohn Company 1,2,8,8A-tetrahydrocyclopropa(c)pyrrolo(3,2-e)-indol-4-(5H)-ones and related compounds
GB8528848D0 (en) * 1985-11-22 1985-12-24 Davy Mckee Poole Rolling mills
WO1988004659A2 (en) * 1986-12-19 1988-06-30 The Upjohn Company Novel cc-1065 analogs

Also Published As

Publication number Publication date
TW217383B (enExample) 1993-12-11
CA1340215C (en) 1998-12-15
JPH04500664A (ja) 1992-02-06
LV12806B (lv) 2002-05-20
GR3035589T3 (en) 2001-06-29
ATE198335T1 (de) 2001-01-15
KR0137959B1 (ko) 1998-05-15
NO910958L (no) 1991-05-10
NO910958D0 (no) 1991-03-11
NO303498B1 (no) 1998-07-20
FI911193A0 (fi) 1991-03-11
DE68929275D1 (de) 2001-02-01
AU632288B2 (en) 1992-12-24
AU4192289A (en) 1990-04-02
WO1990002746A1 (en) 1990-03-22
JP3380237B2 (ja) 2003-02-24
US5541339A (en) 1996-07-30
LV12806A (en) 2002-03-20
DE68929275T2 (de) 2001-05-23
DK41791D0 (da) 1991-03-08
KR900701801A (ko) 1990-12-04
DK41791A (da) 1991-03-08
DK175458B1 (da) 2004-11-01
FI103668B (fi) 1999-08-13

Similar Documents

Publication Publication Date Title
FI103668B1 (fi) Menetelmä farmakologisesti aktiivisten pyrrolo[3,2-e]indol-4(5H)-onidimeerien valmistamiseksi
TR200000197T2 (tr) Yeni bileşimler
KR960009264B1 (en) Novel cc-1065 analogs
TR200000151T2 (tr) Yeni bileşimler.
TR200101567T2 (tr) Yeni triazolo(4.5-D)pirimidin bileşimleri.
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
ATE50763T1 (de) Tetralin-derivate, ihre herstellung und verwendung.
DK0631575T3 (da) Substituerede pyrimidiner samt deres anvendelse som fungicider
WO1992007830A3 (en) Oxindole peptide antagonists
NO20000313L (no) Nye forbindelser
FI865233A0 (fi) Pyrazolinderivat, deras framstaellning och anvaendning som medel med insekticid och akaricid verkan.
SE9702564D0 (sv) New compounds
BR9907934A (pt) Composto, composição farmacêutica, e, processo para a preparação do composto
ES2037670T3 (es) Procedimiento para la preparacion de complejos de (2,2-bis(aminometil)-1,3-propanodiol-n,n') platino.
DE3769691D1 (de) Substituierte oximether, ihre verwendung als bioregulatoren zur senkung des endogenen ethylenspiegels in pflanzen.
SE9802574D0 (sv) Novel compounds
FI875501A0 (fi) 6,7-dihydro-/1,2,4/triazolo/1,5-a// 1,3,5/triazin-2-sulfonsyraamider, foerfarande foer deras framstaellning och deras anvaendning som medel med herbicid och vaextreglerande verkan.
NZ208996A (en) 5-substituted(1,2,4 triazpyrimidin-2-amine derivatives and pharmaceutical compositions
BE898856A (fr) Analogues de mitomycine
DE3782831D1 (de) (gem-heterocyclodimethanamin-n,n')platin komplexe.
ATE41003T1 (de) Tetrazolothienopyridine.
BR8108862A (pt) Hidroximidato e tiol-hidroximidatos heterobiciclicos e seus derivados ester -carbamato com atividade biologica

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: PHARMACIA & UPJOHN COMPANY

MA Patent expired